CTRI/2017/09/009674已完成4 期
Clinical correlation and expression of Zeb1, Twist and E-cadherin in patients with oral submucous fibrosis and oral cancer
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Clinically & Histopatholically proven cases of OSMF
- •a positive history of chewing areca nut, tobacco, betel quid, smoking and alcohol
- •difficulty in swallowing, chewing and burning sensation on eating spicy foods
- •restricted mouth opening and changes in the oral mucous membrane including the presence of palpable vertical fibrous bands, stiffness and blanching.
排除标准
- •those who are not willing to participate
- •patients who are already undertaking some treatment for existing potentially malignant oral disorder
- •patients with severe systemic disorder
研究者
相似试验
Unknown
不适用
The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric CancerStomach NeoplasmsNCT02431078wei bo100
已完成
2 期
Clinical evaluation effects of ZAX.1400.C01 in patients with coronavirusIncidence of inflammation due to the mechanism of COVID19.COVID-19U07.1IRCT20210218050404N2Fasa University of Medical Sciences60
进行中（未招募）
1 期
ZEUS – A research study to look at how ziltivekimab works compared to placebo in people with cardiovascular disease, chronic kidney disease and inflammatioAtherosclerotic cardiovascular diseaseChronic kidney disease Systemic inflammationMedDRA version: 26.0Level: LLTClassification code 10051615Term: Atherosclerotic cardiovascular diseaseSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.1Level: LLTClassification code 10067394Term: hs-CRP increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 21.0Level: LLTClassification code 10011418Term: CRP increasedSystem Organ Class: 10022891 - InvestigationsEUCTR2020-004853-59-LTovo Nordisk A/S6,200
进行中（未招募）
1 期
ZEUS – A research study to look at how ziltivekimab works compared to placebo in people with cardiovascular disease, chronic kidney disease and inflammatioEUCTR2020-004853-59-CZovo Nordisk A/S6,200
进行中（未招募）
1 期
ZEUS – A research study to look at how ziltivekimab works compared to placebo in people with cardiovascular disease, chronic kidney disease and inflammatioAtherosclerotic cardiovascular diseaseChronic kidney disease Systemic inflammationMedDRA version: 26.0Level: LLTClassification code 10051615Term: Atherosclerotic cardiovascular diseaseSystem Organ Class: 100000004866MedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.1Level: LLTClassification code 10067394Term: hs-CRP increasedSystem Organ Class: 100000004848MedDRA version: 21.0Level: LLTClassification code 10011418Term: CRP increasedSystem Organ Class: 100000004848EUCTR2020-004853-59-GRovo Nordisk A/S6,200